4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001181431-04-027054
President and CEO acquired 2,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
DRISCOLL FREDERICK W · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2004-05-20 | Grant or award : show line 1 in the form | +2,000 | $7.31 | $14,620 | 40,000 | D |
Loading xslF345X02/rrd43212.xml…